COVID-19 Vaccine Hesitancy among Parents of Children under Five Years in the United States

On 17 June 2022, the U.S. FDA authorized the Pfizer-BioNTech and Moderna COVID-19 (SARS-CoV-2) vaccines for emergency use (EUA) in children ages 6 months–4 years. Seroprevalence has increased during the current Omicron variant wave for children under 5 years, and the burden of hospitalization for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisher, Celia B., Bragard, Elise, Jaber, Rimah, Gray, Aaliyah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413913/
https://www.ncbi.nlm.nih.gov/pubmed/36016200
http://dx.doi.org/10.3390/vaccines10081313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413913/
https://www.ncbi.nlm.nih.gov/pubmed/36016200
http://dx.doi.org/10.3390/vaccines10081313

Ejemplares similares